MAPT and Alzheimer disease: Although sex differences can be partially explained by a longer life expectancy in women, alternative sex-driven differences in the biological mechanisms underlying AD have been suggested as well, such as a greater association between Apolipoprotein E and CSF tau levels in women, especially in amyloid-positive patients [93].